Latest Insider Transactions at Allogene Therapeutics, Inc. (ALLO)
This section provides a real-time view of insider transactions for Allogene Therapeutics, Inc. (ALLO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Allogene Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Allogene Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2023
|
David D Chang President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,924,464
+31.45%
|
-
|
|
Mar 14
2023
|
David D Chang President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
22,340
-0.97%
|
$111,700
$5.56 P/Share
|
|
Mar 14
2023
|
Eric Thomas Schmidt Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
35,879
-10.55%
|
$179,395
$5.47 P/Share
|
|
Mar 14
2023
|
Alison Moore Chief Technical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,351
-6.79%
|
$41,755
$5.51 P/Share
|
|
Mar 14
2023
|
Veer Bhavnagri General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
23,628
-4.08%
|
$118,140
$5.67 P/Share
|
|
Feb 13
2023
|
Veer Bhavnagri General Counsel |
SELL
Open market or private sale
|
Direct |
3,000
-0.52%
|
$18,000
$6.85 P/Share
|
|
Jan 20
2023
|
Zachary Roberts EVP of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
251,908
+50.0%
|
-
|
|
Jan 17
2023
|
Veer Bhavnagri General Counsel |
SELL
Open market or private sale
|
Direct |
3,000
-0.51%
|
$21,000
$7.04 P/Share
|
|
Dec 15
2022
|
Veer Bhavnagri General Counsel |
SELL
Open market or private sale
|
Direct |
5,602
-0.95%
|
$39,214
$7.53 P/Share
|
|
Oct 07
2022
|
Rafael Amado EVP of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
8,464
-1.54%
|
$93,104
$11.83 P/Share
|
|
Oct 07
2022
|
Rafael Amado EVP of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
19,120
+3.36%
|
-
|
|
Oct 03
2022
|
Rafael Amado EVP of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
8,968
-1.66%
|
$98,648
$11.06 P/Share
|
|
Aug 12
2022
|
Owen N. Witte |
SELL
Open market or private sale
|
Direct |
10,000
-2.24%
|
$170,000
$17.25 P/Share
|
|
Aug 11
2022
|
Owen N. Witte |
SELL
Open market or private sale
|
Direct |
20,000
-4.29%
|
$320,000
$16.5 P/Share
|
|
Aug 02
2022
|
Rafael Amado EVP of R&D |
SELL
Open market or private sale
|
Direct |
2,000
-0.37%
|
$22,000
$11.97 P/Share
|
|
Jul 08
2022
|
Stephen Mayo |
BUY
Grant, award, or other acquisition
|
Direct |
35,328
+50.0%
|
-
|
|
Jul 05
2022
|
Rafael Amado EVP of R&D |
SELL
Open market or private sale
|
Direct |
2,000
-0.37%
|
$22,000
$11.44 P/Share
|
|
Jun 22
2022
|
Owen N. Witte |
SELL
Open market or private sale
|
Direct |
10,000
-4.11%
|
$110,000
$11.76 P/Share
|
|
Jun 21
2022
|
Rafael Amado EVP of R&D |
SELL
Open market or private sale
|
Direct |
2,000
-0.37%
|
$22,000
$11.18 P/Share
|
|
Jun 15
2022
|
Owen N. Witte |
BUY
Grant, award, or other acquisition
|
Direct |
22,089
+8.32%
|
-
|
|
Jun 15
2022
|
Joshua A Kazam |
BUY
Grant, award, or other acquisition
|
Direct |
44,178
+12.72%
|
-
|
|
Jun 15
2022
|
Vicki L Sato |
BUY
Grant, award, or other acquisition
|
Direct |
22,089
+34.76%
|
-
|
|
Jun 15
2022
|
Franz B Humer Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,178
+18.71%
|
-
|
|
May 19
2022
|
Rafael Amado EVP of R&D |
SELL
Open market or private sale
|
Direct |
11,500
-2.06%
|
$80,500
$7.4 P/Share
|
|
Mar 31
2022
|
Pf Equity Holdings 2 B.V. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
22,032,040
-100.0%
|
-
|
|
Mar 23
2022
|
Veer Bhavnagri General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
175,438
+22.94%
|
-
|
|
Mar 23
2022
|
Eric Thomas Schmidt Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
237,358
+41.26%
|
-
|
|
Mar 23
2022
|
Rafael Amado EVP of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
237,358
+29.86%
|
-
|
|
Mar 15
2022
|
Alison Moore Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
8,698
-6.74%
|
$60,886
$7.63 P/Share
|
|
Mar 15
2022
|
Eric Thomas Schmidt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,469
-10.24%
|
$80,283
$7.63 P/Share
|
|
Mar 15
2022
|
David D Chang President and CEO |
SELL
Open market or private sale
|
Direct |
23,648
-1.02%
|
$165,536
$7.65 P/Share
|
|
Mar 15
2022
|
Veer Bhavnagri General Counsel |
SELL
Open market or private sale
|
Direct |
8,849
-2.09%
|
$61,943
$7.68 P/Share
|
|
Mar 15
2022
|
Rafael Amado EVP of R&D |
SELL
Open market or private sale
|
Direct |
5,169
-1.59%
|
$36,183
$7.71 P/Share
|
|
Mar 14
2022
|
Arie Belldegrun Director |
BUY
Other acquisition or disposition
|
Indirect |
4,710,121
+50.0%
|
-
|
|
Mar 14
2022
|
Arie Belldegrun Director |
SELL
Other acquisition or disposition
|
Indirect |
4,710,121
-100.0%
|
-
|
|
Mar 07
2022
|
Joshua A Kazam |
SELL
Bona fide gift
|
Direct |
412,618
-61.45%
|
-
|
|
Mar 07
2022
|
Joshua A Kazam |
BUY
Other acquisition or disposition
|
Direct |
412,618
+38.06%
|
-
|
|
Jan 12
2022
|
Arie Belldegrun Director |
BUY
Open market or private purchase
|
Indirect |
155,039
+44.29%
|
$1,860,468
$12.6 P/Share
|
|
Jan 12
2022
|
Joshua A Kazam |
BUY
Open market or private purchase
|
Direct |
15,000
+5.48%
|
$180,000
$12.6 P/Share
|
|
Oct 01
2021
|
Rafael Amado EVP of R&D |
SELL
Open market or private sale
|
Direct |
11,507
-3.43%
|
$276,168
$24.35 P/Share
|
|
Sep 15
2021
|
Veer Bhavnagri General Counsel |
SELL
Open market or private sale
|
Direct |
5,000
-1.17%
|
$120,000
$24.77 P/Share
|
|
Sep 15
2021
|
Veer Bhavnagri General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.16%
|
$10,000
$2.27 P/Share
|
|
Sep 09
2021
|
Owen N. Witte |
SELL
Open market or private sale
|
Direct |
5,000
-2.21%
|
$125,000
$25.54 P/Share
|
|
Aug 20
2021
|
Owen N. Witte |
SELL
Open market or private sale
|
Direct |
10,000
-2.14%
|
$230,000
$23.47 P/Share
|
|
Aug 16
2021
|
Veer Bhavnagri General Counsel |
SELL
Open market or private sale
|
Direct |
5,000
-1.17%
|
$105,000
$21.0 P/Share
|
|
Aug 16
2021
|
Veer Bhavnagri General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.16%
|
$10,000
$2.27 P/Share
|
|
Jul 30
2021
|
Vicki L Sato |
BUY
Grant, award, or other acquisition
|
Direct |
19,362
+50.0%
|
-
|
|
Jul 15
2021
|
Veer Bhavnagri General Counsel |
SELL
Open market or private sale
|
Direct |
5,000
-1.17%
|
$105,000
$21.55 P/Share
|
|
Jul 15
2021
|
Veer Bhavnagri General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.16%
|
$10,000
$2.27 P/Share
|
|
Jun 15
2021
|
Veer Bhavnagri General Counsel |
SELL
Open market or private sale
|
Direct |
5,000
-1.17%
|
$125,000
$25.32 P/Share
|